Comparison between the efficacy and safety of podophyllin resin versus cryotherapy in treatment of anogenital warts
DOI:
https://doi.org/10.66344/jpad.v29i4.1387Keywords:
Genital warts, human papillomavirus, cryotherapy, topical podophyllin resin, condylomata acuminataAbstract
Objective To compare the efficacy and safety of podophyllin resin VS cryotherapy in treatment of anogenital warts.
Methods A total of 104 patients were enrolled, 52 in each group A & B. Group A was treated with cryotherapy and Group B was treated with podophyllin resin. Findings were noted in already devised proforma. Patients were evaluated at last follow up visit to assess results.
Results 88% of patients in group a showed excellent results at the end of treatment whereas this figure was 8% in group B.
Conclusion Cryotherapy was found to be more effective and safe than podophyllin resin in treatment of anogenital warts.
References
1. Oriel J D. Natural History OF Anogenital warts: Br J Vener Dis 1971; 47: 1-13.
2. Jeffrey Scooper: Warts: e Medicine Retreived on February 2008.
3. Peter A Gearhart: Human Papilloma Virus: eMedicine. Retreived on February 2008.
4. Von Krogh G. Penile condylomata acuminata: an experimental model for evaluation of topical treatment with 0.5%-1.0% ethanolic preparations of podophyllotoxin for three days. Sex Transm Dis 1991; 8: 179–84.
5. Sterling JC, Handfield-Jones S, Hudson PM; British Association of Dermatologists. Guidelines for the management of cutaneous warts. Br J Dermatol 2001; 144: 4-11.
6. Stephen Tyring, Libby Edwards, Lisa K Cherry, William M Ramsdell, Steven kotner, Mitchell D. Safety and efficacy of 0.5% podofilox gel in treatment of anogenital warts. Arch Dermatol. 1998; 134(1): 33-38.
7. Tsu-Yi C, Dirk ME. Genital Warts. Updated: 30, 2012.
8. Steben M, Duarte-Franco E. Human papillomavirus infection: Epidemiology and pathophysiology. Gynecologic Oncology 2007; 107: S2–S5.
9. Strand A, Brinkeborn R-M, Siboulet A. Topical treatment of genital warts in men, an open study of podophyllotoxin cream compared with solution. Genitourin Med 1995; 71: 387–90.
10. Weinstock H, Berman S, Cates Jr W. Sexually transmitted diseases among american youth: incidence and prevalence estimates, 2000. Perspect Sex Reprod health 2004; 36: 6–10.
11. Scheinfeld N, Daniel SL. An evidence-based review of medical and surgical treatments of genital warts. Dermatology Online Journal 2006; 12: 5.
12. Connolly M, Bazmi K, O’Connell M, Lyons JF, Bourke JF. Cryotherapy of viral warts: a sustained 10-s freeze is more effective than the traditional method. Br J Dermatol 2001; 145: 554-557.
13. Bourke JF, Berth-Jones J, Hutchinson PE. Cryotherapy of common viral warts at intervals of 1, 2 and 3 weeks. Br J Dermatol 1995; 132: 433-436.
14. Stone KM, Becker TM, Hadgu A, Kraus SJ. Treatment of external genital warts: a randomised clinical trial comparing podophyllin, cryotherapy, and electrodesiccation. Genitourin Med 1990; 66: 16-19.
15. Pouran Layegh, Pezeshkpoor F.A.Z., Emam Gholi Tabar Malekshah P., Shakeri M.T. Cryotherapy versus podophyllin in treatment of genital warts. Ir J Obs, Gyn and Inf 2008; 10(2): 133-138.
16. Bashi SA.. Cryotherapy versus podophyllin in the treatment of genital warts. Int J Dermatol1985 Oct; 24(8): 535-6.
17. A Edwards, A Atma-Ram, R N Thin. Podophyllotoxin 0.5% v podophyllin 20% to treat penile warts. Genitourin Med. 1988 Aug; 64(4): 263-265.
18. Kinghorn GR, McMillan A, Mulcahy F. An open comparative study of the efficacy of 0.5% podophyllotoxin lotion and 25% podophyllin solution in the treatment of condylomata acuminata in males and females. Int J STD AIDS 1993; 4: 194–9.
19. Strand A, Brinkeborn R-M, Siboulet A. Topical treatment of genital warts in men, an open study of podophyllotoxin cream compared with solution. Genitourin Med 1995; 71: 387–390.
Downloads
Published
Issue
Section
License
Copyright (c) 2019 syed ahmed kazmi, kehkshan tahir, asma nasir, shaiqa ali, shahbaz aman, muhammad nadeem
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
